The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent ...

Experts warn that downplaying risks of untreated maternal depression could endanger pregnant individuals and their babies. Last Monday, an expert panel convened by the U.S. Food and Drug ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

The Food and Drug Administration, making good on a Trump administration promise to examine the usage of antidepressants, on ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...